AMERICAN REBEL HOLDINGS INC (AREB)

US02919L3078 - Common Stock

0.3212  -0.03 (-7.97%)

Fundamental Rating

2

AREB gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. AREB may be in some trouble as it scores bad on both profitability and health. AREB is not valued too expensively and it also shows a decent growth rate.



0

1. Profitability

1.1 Basic Checks

AREB had negative earnings in the past year.
In the past year AREB has reported a negative cash flow from operations.
In the past 5 years AREB always reported negative net income.
AREB had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

AREB has a worse Return On Assets (-75.80%) than 96.39% of its industry peers.
AREB has a worse Return On Equity (-158.72%) than 86.75% of its industry peers.
Industry RankSector Rank
ROA -75.8%
ROE -158.72%
ROIC N/A
ROA(3y)-249.25%
ROA(5y)-337.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AREB's Gross Margin of 18.72% is on the low side compared to the rest of the industry. AREB is outperformed by 67.47% of its industry peers.
AREB's Gross Margin has declined in the last couple of years.
AREB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.72%
GM growth 5Y-21.19%

2

2. Health

2.1 Basic Checks

AREB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AREB has been increased compared to 1 year ago.
The number of shares outstanding for AREB has been increased compared to 5 years ago.
The debt/assets ratio for AREB is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -4.55, we must say that AREB is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -4.55, AREB is doing worse than 92.77% of the companies in the same industry.
AREB has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of AREB (0.49) is better than 61.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF N/A
Altman-Z -4.55
ROIC/WACCN/A
WACC13.77%

2.3 Liquidity

A Current Ratio of 1.52 indicates that AREB should not have too much problems paying its short term obligations.
AREB has a Current ratio (1.52) which is in line with its industry peers.
A Quick Ratio of 0.62 indicates that AREB may have some problems paying its short term obligations.
The Quick ratio of AREB (0.62) is worse than 90.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 0.62

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 91.79% over the past year.
The Revenue has grown by 92.25% in the past year. This is a very strong growth!
AREB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 162.58% yearly.
EPS 1Y (TTM)91.79%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q16.14%
Revenue 1Y (TTM)92.25%
Revenue growth 3Y134.41%
Revenue growth 5Y162.58%
Revenue growth Q2Q24.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y266.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.58%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

AREB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 2.86 indicates a rather cheap valuation of AREB.
Based on the Price/Forward Earnings ratio, AREB is valued cheaper than 100.00% of the companies in the same industry.
AREB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.02.
Industry RankSector Rank
PE N/A
Fwd PE 2.86

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AREB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN REBEL HOLDINGS INC

NASDAQ:AREB (5/1/2024, 1:15:52 PM)

0.3212

-0.03 (-7.97%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.91M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.86
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -75.8%
ROE -158.72%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 18.72%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.52
Quick Ratio 0.62
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)91.79%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y266.67%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)92.25%
Revenue growth 3Y134.41%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y